ask="4.22"
ask_size="200"
average_daily_volume="125462"
bid="4.16"
bid_size="2300"
book_value="1.98"
change="+0.38"
change_from_200_day_moving_average="-0.14"
change_from_50_day_moving_average="0.34"
change_from_52_week_high="-4.07"
change_From_52_week_low="0.86"
change_in_percent="+10.27%"
close="4.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.30"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.13"
ex_dividend_date="N/A"
float_shares="8580000"
high="4.20"
high_52_weeks="8.15"
last_trade_date="1/4/2017"
last_trade_price="4.08"
last_trade_size="842"
last_trade_time="4:00pm"
low="3.74"
low_52_weeks="3.22"
market_capitalization="76.10M"
moving_average_200_day="4.22"
moving_average_50_day="3.74"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="18.00"
open="3.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.21%"
percent_change_from_50_day_moving_average="+9.03%"
percent_change_from_52_week_high="-49.94%"
percent_change_from_52_week_low="+26.71%"
previous_close="3.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.87"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="2.34"
stock_exchange="NGM"
symbol="CATB"
volume="190141"
weeks_range_52="3.22 - 8.15"
